Short Chain Fatty Acids and Gallates Composition for Metabolic Health
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for less expensive dietary and nutritional supplements that effectively reduce inflammation, assist with weight loss, and help prevent heart disease, as current pharmaceutical products are costly and not widely accessible.
Innovation Solution
Compositions combining short chain fatty acids, such as butyrate, with epigallocatechin gallate (EGCG) and optionally beta-hydroxybutyrate, which can be administered orally to induce ketosis, activate uncoupling protein 1, and modulate Sirtuin protein expression, thereby reducing inflammation, aiding weight loss, and preventing heart disease.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmaceutical products are used to reduce inflammation, assist with weight loss, and prevent heart disease, then therapeutic effectiveness is improved, but cost and accessibility deteriorate
Solution Approach 1:
The patent replaces expensive pharmaceutical products with a cost-effective dietary supplement composition containing short chain fatty acids, gallates, and ketones. This composition can be manufactured at lower cost through natural extraction or synthesis of the active ingredients, making therapeutic intervention more accessible while maintaining effectiveness for reducing inflammation, assisting weight loss, and preventing heart disease
Solution Approach 2:
The invention combines multiple bioactive compounds (short chain fatty acids, gallates, and ketones) into a synergistic composition. This composite formulation enhances therapeutic effectiveness by targeting multiple metabolic pathways simultaneously, while the use of naturally-derived ingredients keeps manufacturing costs lower than conventional pharmaceuticals
2Ease of manufacture
If dietary supplements are used to reduce inflammation, assist with weight loss, and prevent heart disease, then accessibility and cost are improved, but therapeutic effectiveness may deteriorate
Solution Approach 1:
The patent formulates a composite composition containing short chain fatty acids (such as butyrate), gallates (such as epigallocatechin gallate), and ketones (such as beta-hydroxybutyrate). These ingredients work synergistically to enhance therapeutic effectiveness while maintaining cost-effectiveness and accessibility as dietary supplements
Solution Approach 2:
The invention optimizes the concentrations and ratios of active ingredients in the composition to achieve therapeutic effectiveness. By carefully controlling the parameters of the formulation (amounts of short chain fatty acids, gallates, and ketones), the composition delivers clinically beneficial effects while remaining affordable and accessible as a dietary supplement
3Speed
If conventional treatments are used for inflammation and weight management, then immediate effects are achieved, but long-term health prevention and metabolic health deteriorate
Solution Approach 1:
The patent creates a multi-functional composition that simultaneously addresses acute symptoms (inflammation reduction, weight management) and long-term prevention (heart disease, metabolic disorders). The combination of short chain fatty acids, gallates, and ketones provides both immediate therapeutic effects and sustained metabolic health benefits, eliminating the need for separate treatments
Data Source
AI summary
Compositions and methods for providing a person with an exogenous and therapeutically effective supply of short chain fatty acids, gallates, and (optionally) one or more ketones are disclosed. The compositions include one or more short chain fatty acids (such as butyric acid, butyrate salts, propionic acid, propionate salts, acetic acid, or acetate salts); epigallocatechin gallate (EGCG); and, optionally, one or more beta-hydroxybutyrate salts. The compositions and methods are useful for inducing weight loss, ketosis, brown adipose fat cell differentiation, and/or beta-oxidative activity in a subject.